Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.

Aiello Bowles EJ, Crane PK, Walker RL, Chubak J, LaCroix AZ, Anderson ML, Rosenberg D, Keene CD, Larson EB.

J Alzheimers Dis. 2019 Mar 18. doi: 10.3233/JAD-180942. [Epub ahead of print]

PMID:
30909217
2.

Use of antidepressants after colon cancer diagnosis and risk of recurrence.

Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J.

Psychooncology. 2019 Jan 31. doi: 10.1002/pon.5015. [Epub ahead of print]

PMID:
30703275
3.

CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy.

Mayer SE, Weiss NS, Chubak J, Doody DR, Carlson CS, Makar KW, Wurscher MA, Malone KE.

Cancer Causes Control. 2019 Jan;30(1):103-112. doi: 10.1007/s10552-018-1117-x. Epub 2018 Dec 12.

PMID:
30542984
4.

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):91-98. doi: 10.1158/1055-9965.EPI-18-0452. Epub 2018 Nov 20.

PMID:
30459208
5.

Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence.

Chen Y, Wang J, Chubak J, Hubbard RA.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):264-268. doi: 10.1002/pds.4680. Epub 2018 Oct 30.

PMID:
30375122
6.

Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V; PROSPR consortium.

Int J Cancer. 2019 Mar 15;144(6):1460-1473. doi: 10.1002/ijc.31940. Epub 2018 Dec 20.

PMID:
30353911
7.

Risk of colon cancer recurrence in relation to diabetes.

Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA.

Cancer Causes Control. 2018 Nov;29(11):1093-1103. doi: 10.1007/s10552-018-1083-3. Epub 2018 Sep 22.

PMID:
30244297
8.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA.

Ann Intern Med. 2018 Oct 2;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18.

PMID:
30242328
9.

Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA.

Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27.

PMID:
29487413
10.

Financial difficulty, worry about affording care, and benefit finding in long-term survivors of cancer.

Jones SMW, Walker R, Fujii M, Nekhlyudov L, Rabin BA, Chubak J.

Psychooncology. 2018 Apr;27(4):1320-1326. doi: 10.1002/pon.4677. Epub 2018 Mar 8.

PMID:
29462511
11.

An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.

Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA.

Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.

12.

Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models.

Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM.

Health Serv Outcomes Res Methodol. 2017 Jun;17(2):101-112. doi: 10.1007/s10742-016-0149-5. Epub 2016 Jun 3.

13.

Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.

Cancer Res. 2017 Nov 1;77(21):6033-6041. doi: 10.1158/0008-5472.CAN-17-0687. Epub 2017 Sep 21.

14.

Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1603-1610. doi: 10.1158/1055-9965.EPI-17-0346. Epub 2017 Aug 14.

15.

A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.

Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW.

Cancer. 2017 Nov 15;123(22):4472-4480. doi: 10.1002/cncr.30908. Epub 2017 Jul 28.

16.

Pilot Study of Therapy Dog Visits for Inpatient Youth With Cancer.

Chubak J, Hawkes R, Dudzik C, Foose-Foster JM, Eaton L, Johnson RH, Macpherson CF.

J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):331-341. doi: 10.1177/1043454217712983. Epub 2017 Jun 14.

PMID:
28614971
17.

Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk.

Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J.

Obs Stud. 2016 Aug;2:51-64. Epub 2016 Sep 26.

18.

Cancer Survivors' Reported Discussions with Health Care Providers About Follow-Up Care and Receipt of Written Care Plans.

Reed SC, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J, Nekhlyudov L.

J Cancer Educ. 2018 Dec;33(6):1181-1188. doi: 10.1007/s13187-017-1228-1.

PMID:
28480500
19.

Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State.

Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA.

Cancer Causes Control. 2017 Mar;28(3):241-246. doi: 10.1007/s10552-017-0866-2. Epub 2017 Feb 15.

20.

Association of worry about cancer to benefit finding and functioning in long-term cancer survivors.

Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J.

Support Care Cancer. 2017 May;25(5):1417-1422. doi: 10.1007/s00520-016-3537-z. Epub 2016 Dec 15.

PMID:
27981365
21.

Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.

Singal AG, Tiro J, Li X, Adams-Huet B, Chubak J.

J Clin Gastroenterol. 2017 Aug;51(7):650-655. doi: 10.1097/MCG.0000000000000708.

22.

Cancer survivors' experiences with insurance, finances, and employment: results from a multisite study.

Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J.

J Cancer Surviv. 2016 Dec;10(6):1104-1111. Epub 2016 Jun 9.

PMID:
27277896
23.

The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.

Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH.

Cancer Causes Control. 2016 Nov;27(11):1315-1323. Epub 2016 Sep 17.

24.

The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N, Buist DSM, Urban N.

Cancer. 2016 Nov 15;122(22):3509-3518. doi: 10.1002/cncr.30190. Epub 2016 Jul 22.

25.

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA; PROSPR consortium.

Am J Prev Med. 2016 Sep;51(3):e67-75. doi: 10.1016/j.amepre.2016.04.018. Epub 2016 Jun 22.

26.

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA.

J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.

27.

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA; PROSPR consortium.

Am J Prev Med. 2016 Oct;51(4):507-12. doi: 10.1016/j.amepre.2016.03.017. Epub 2016 Apr 28.

28.

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.

Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML.

Ann Intern Med. 2016 Jun 21;164(12):814-25. doi: 10.7326/M15-2117. Epub 2016 Apr 12. Review.

PMID:
27064482
29.

Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.

Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA; PROSPR Consortium.

Am J Prev Med. 2016 Oct;51(4):e107-15. doi: 10.1016/j.amepre.2016.02.025. Epub 2016 Apr 1.

30.

Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH).

Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW.

J Am Board Fam Med. 2016 Mar-Apr;29(2):191-200. doi: 10.3122/jabfm.2016.02.150290.

31.

Defining and measuring adherence to cancer screening.

Chubak J, Hubbard R.

J Med Screen. 2016 Dec;23(4):179-185. Epub 2016 Mar 4.

32.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.

33.

Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.

Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):513-20. doi: 10.1158/1055-9965.EPI-15-0824. Epub 2015 Dec 31.

34.

Animal-Assisted Activities: Results From a Survey of Top-Ranked Pediatric Oncology Hospitals.

Chubak J, Hawkes R.

J Pediatr Oncol Nurs. 2016 Jul;33(4):289-96. doi: 10.1177/1043454215614961. Epub 2015 Nov 20.

35.

Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.

Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ.

J Natl Cancer Inst. 2015 Nov 18;108(3). pii: djv336. doi: 10.1093/jnci/djv336. Print 2016 Mar. Erratum in: J Natl Cancer Inst. 2016 Mar;108(3). pii: djw025. doi: 10.1093/jnci/djw025. J Natl Cancer Inst. 2016 Mar;108(3). pii: djw017. doi: 10.1093/jnci/djw017.

36.

Breast cancer recurrence in relation to antidepressant use.

Chubak J, Bowles EJ, Yu O, Buist DS, Fujii M, Boudreau DM.

Cancer Causes Control. 2016 Jan;27(1):125-36. doi: 10.1007/s10552-015-0689-y. Epub 2015 Oct 30.

37.

Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Chubak J, Kamineni A, Buist DSM, Anderson ML, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

38.

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.

Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW.

Cancer. 2016 Jan 15;122(2):312-21. doi: 10.1002/cncr.29734. Epub 2015 Oct 21.

39.

Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data.

Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, Williams AE, Weinmann S, Doria-Rose VP, Rutter CM.

EGEMS (Wash DC). 2015 May 18;3(1):1171. doi: 10.13063/2327-9214.1171. eCollection 2015.

40.

Psychometric investigation of benefit finding among long-term cancer survivors using the Medical Expenditure Panel Survey.

Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J.

Eur J Oncol Nurs. 2016 Feb;20:31-5. doi: 10.1016/j.ejon.2015.07.005. Epub 2015 Jul 26.

41.

An economic evaluation of colorectal cancer screening in primary care practice.

Meenan RT, Anderson ML, Chubak J, Vernon SW, Fuller S, Wang CY, Green BB.

Am J Prev Med. 2015 Jun;48(6):714-21. doi: 10.1016/j.amepre.2014.12.016.

42.

Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation?

Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH.

Gen Hosp Psychiatry. 2015 May-Jun;37(3):236-9. doi: 10.1016/j.genhosppsych.2015.02.008. Epub 2015 Feb 28.

43.

Estimating screening test utilization using electronic health records data.

Hubbard R, Chubak J, Rutter C.

EGEMS (Wash DC). 2014 Nov 4;2(1):14.

44.

Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM.

J Med Screen. 2015 Jun;22(2):69-75. doi: 10.1177/0969141314562036. Epub 2014 Dec 9.

45.

Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial.

Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S.

J Am Board Fam Med. 2014 Nov-Dec;27(6):789-95. doi: 10.3122/jabfm.2014.06.140125.

46.

Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer.

Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N.

Behav Med. 2016;42(1):18-28. doi: 10.1080/08964289.2014.947234. Epub 2014 Nov 3.

47.

Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.

Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB.

Prev Med. 2014 Sep;66:123-30. doi: 10.1016/j.ypmed.2014.06.013. Epub 2014 Jun 15.

48.

The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.

Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1147-58. doi: 10.1158/1055-9965.EPI-13-1217. Epub 2014 Jun 10.

49.

Time to screening in the systems of support to increase colorectal cancer screening trial.

Wang CY, de Dieu Tapsoba J, Anderson ML, Vernon SW, Chubak J, Fuller S, Green BB.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1683-8. doi: 10.1158/1055-9965.EPI-14-0270. Epub 2014 Jun 2.

50.

Patterns of colorectal cancer screening uptake in newly eligible men and women.

Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1230-7. doi: 10.1158/1055-9965.EPI-13-1360. Epub 2014 May 3.

Supplemental Content

Loading ...
Support Center